Literature DB >> 30456505

Is laparoscopic left adrenalectomy with the anterior submesocolic approach for Conn's or Cushing's syndrome equally safe and effective as the lateral and anterior ones?

Andrea Balla1, Silvia Quaresima2, Livia Palmieri2, Monica Ortenzi3, Emilia Sbardella4, Giulia Puliani4, Andrea M Isidori4, Mario Guerrieri3, Alessandro M Paganini2.   

Abstract

BACKGROUND: The aim of the present study is to report and to compare the results of three different laparoscopic transperitoneal surgical approaches [lateral transperitoneal (LT), anterior transperitoneal (AT) and anterior transperitoneal submesocolic (ATS)] for the treatment of Conn's and Cushing's syndrome from left adrenal disease.
METHODS: This study is a retrospective analysis of prospectively collected data. From 1994 to 2017, 535 laparoscopic adrenalectomies (LA) were performed. One hundred and sixty-four patients with Conn's or Cushing's syndrome underwent left LA. Patients were divided in three groups based on the approach: LT (Group A), AT (Group B) and ATS (Group C).
RESULTS: The diagnosis was Conn's and Cushing's syndrome in 99 and 65 patients, respectively. LT was used in 13 cases, AT in 55 and ATS in 96. No significant differences in patient's gender, age and BMI were observed. Mean operative time was 117.6 ± 33.7, 107.6 ± 40.3 and 96.2 ± 47.5 min for Groups A, B and C, respectively. Conversion to open surgery was observed in 4 Group C patients (4.1%). Morbidity occurred in 2 Group B (2%) and in 5 Group C patients (5.2%).
CONCLUSIONS: In case of Conn's or Cushing's syndrome, left LA with ATS approach is equally safe and effective as compared to the LT and AT approaches. Early control of the adrenal vein with minimal gland manipulation and limited surgical dissection are the major advantages of the submesocolic approach. Even if statistically significant differences are not observed, postoperative results are the same as those reported in the literature with other approaches.

Entities:  

Keywords:  Conn’s syndrome; Cushing’s syndrome; Laparoscopic adrenalectomy; Lateral approach; Submesocolic approach; Transperitoneal anterior approach

Mesh:

Year:  2018        PMID: 30456505     DOI: 10.1007/s00464-018-6601-6

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  35 in total

1.  [Preoperative and postoperative management of adrenal masses].

Authors:  R M Paragliola; M P Ricciato; F Gallo; A De Rosa; F Ianni; P Locantore; P Senes; A Pontecorvi; S M Corsello
Journal:  G Chir       Date:  2010 Jun-Jul

2.  The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.

Authors:  Lynnette K Nieman; Beverly M K Biller; James W Findling; John Newell-Price; Martin O Savage; Paul M Stewart; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2008-03-11       Impact factor: 5.958

3.  Flank approach versus anterior sub-mesocolic access in left laparoscopic adrenalectomy: a prospective randomized study.

Authors:  E Lezoche; M Guerrieri; F Crosta; G Lezoche; M Baldarelli; R Campagnacci
Journal:  Surg Endosc       Date:  2008-02-21       Impact factor: 4.584

4.  SAGES guidelines for minimally invasive treatment of adrenal pathology.

Authors:  Dimitrios Stefanidis; Melanie Goldfarb; Kent W Kercher; William W Hope; William Richardson; Robert D Fanelli
Journal:  Surg Endosc       Date:  2013-09-10       Impact factor: 4.584

Review 5.  Surgical strategy in adrenal masses.

Authors:  Gerhard Prager; Gertraud Heinz-Peer; Christian Passler; Klaus Kaczirek; Martin Schindl; Christian Scheuba; Bruno Niederle
Journal:  Eur J Radiol       Date:  2002-01       Impact factor: 3.528

Review 6.  Laparoscopic adrenalectomy.

Authors:  M Gagner
Journal:  Surg Clin North Am       Date:  1996-06       Impact factor: 2.741

7.  Hemodynamic instability during surgery for pheochromocytoma: comparing the transperitoneal and retroperitoneal approach in a multicenter analysis of 341 patients.

Authors:  Wessel M C M Vorselaars; Emily L Postma; Eric Mirallie; Julien Thiery; Mattan Lustgarten; Jesse D Pasternak; Rocco Bellantone; Marco Raffaelli; Thomas Fahey; Menno R Vriens; Laurent Bresler; Laurent Brunaud; Rasa Zarnegar
Journal:  Surgery       Date:  2017-11-06       Impact factor: 3.982

8.  Laparoscopic vs open adrenalectomy for benign adrenal neoplasm.

Authors:  D Hazzan; E Shiloni; D Golijanin; O Jurim; D Gross; P Reissman
Journal:  Surg Endosc       Date:  2001-08-16       Impact factor: 4.584

9.  A Comparison of Two Approaches to Laparoscopic Adrenalectomy: Lateral Transperitoneal Versus Posterior Retroperitoneal Approach.

Authors:  Magda Marek-Safiejko; Kamil Safiejko; Jerzy Łukaszewicz; Jacek Dadan; Robert J Ładny; Robert Kozłowski; Piotr Wojskowicz; Piotr Myśliwiec
Journal:  Adv Clin Exp Med       Date:  2016 Sep-Oct       Impact factor: 1.727

10.  Laparoscopic transperitoneal anterior adrenalectomy.

Authors:  Daniele Scoglio; Andrea Balla; Marcello Paci; Mario Guerrieri; Giovanni Lezoche; Giancarlo D'Ambrosio; Bernardina Fabiani; Pietro Ursi; Alessandro M Paganini
Journal:  Ann Ital Chir       Date:  2013 Jul-Aug       Impact factor: 0.766

View more
  3 in total

1.  Laparoscopic bilateral anterior transperitoneal adrenalectomy: 24 years experience.

Authors:  Andrea Balla; Monica Ortenzi; Livia Palmieri; Diletta Corallino; Francesca Meoli; Pietro Ursi; Giulia Puliani; Emilia Sbardella; Andrea M Isidori; Mario Guerrieri; Silvia Quaresima; Alessandro M Paganini
Journal:  Surg Endosc       Date:  2019-01-23       Impact factor: 4.584

2.  Are Adrenal Lesions of 6 cm or More in Diameter a Contraindication to Laparoscopic Adrenalectomy? A Case-Control Study.

Authors:  Andrea Balla; Livia Palmieri; Francesca Meoli; Diletta Corallino; Monica Ortenzi; Pietro Ursi; Mario Guerrieri; Silvia Quaresima; Alessandro M Paganini
Journal:  World J Surg       Date:  2020-03       Impact factor: 3.352

3.  Cancer risk in adrenalectomy: are adrenal lesions equal or more than 4 cm a contraindication for laparoscopy?

Authors:  Andrea Balla; Diletta Corallino; Monica Ortenzi; Livia Palmieri; Francesca Meoli; Mario Guerrieri; Alessandro M Paganini
Journal:  Surg Endosc       Date:  2021-03-01       Impact factor: 4.584

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.